Reduced peak aerobic capacity in asymptomatic left ventricular systolic dysfunction. A substudy of the studies of left ventricular dysfunction (SOLVD). SOLVD Investigator. Studies of Left Ventricular Dysfunction.

The Ross procedure outcomes in patients with left ventricular dysfunction are presented. 20 Ross procedures were performed in patients with aortic disease complicated by severe left ventricular dysfunction. The average left ventricular ejection fraction before surgery was 31,56,57%. Aortic stenosis was found in 60% of cases. Hospital mortality rate was 5%. Heart failure prevailed among complications. It was already in the early postoperative period that significant left ventricular remodeling was observed. The patients with aortic stenosis demonstrated a 56,9 % increase in ejection fraction, while their end-systolic diameter and end-systolic volume decreased by 34,5% and 13,3% respectively. In the group with aortic insufficiency there was a statistically significant reduction in the left ventricular volume indices: left ventricular end-diastolic diameter by 20%, left ventricular end-diastolic volume by 36,5%. No reoperation due to dysfunction of the autograft and conduits in the pulmonary artery area was required. At 12 months after surgery the processes of left ventricular cavity remodeling and normalization of contractility in both groups continued. The results of this study show that the Ross procedure can be used successfully in patients with severe left ventricular systolic dysfunction.

Download Full-text

Beta-adrenergic blocking agent use and mortality in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a post hoc analysis of the studies of left ventricular dysfunction

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(98)00675-5 ◽

1999 ◽

Vol 33 (4) ◽

pp. 916-923 ◽

Cited By ~ 101

Author(s):

Derek V Exner ◽

Daniel L Dries ◽

Myron A Waclawiw ◽

Brent Shelton ◽

Michael J Domanski

Keyword(s):

Left Ventricular Dysfunction ◽

Ventricular Dysfunction ◽

Left Ventricular Systolic Dysfunction ◽

Systolic Dysfunction ◽

Blocking Agent ◽

Left Ventricular ◽

Ventricular Systolic Dysfunction ◽

Post Hoc Analysis ◽

Post Hoc ◽

Adrenergic Blocking

Download Full-text

EVALUATION OF LEFT VENTRICULAR DYSFUNCTION BY ECHO-DOPPLER IN CONTINUOUS AMBULATORY PERITONEAL DIALYSIS PATIENTS

Journal of Medicine and Pharmacy ◽

10.34071/jmp.2013.2.3 ◽

2013 ◽

pp. 18-24

Author(s):

Tam Vo ◽

Viet Thang Hoang

Keyword(s):

Peritoneal Dialysis ◽

Left Ventricular Dysfunction ◽

Ventricular Dysfunction ◽

Left Ventricular Systolic Dysfunction ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Central Hospital ◽

Ventricular Systolic Dysfunction ◽

Cross Sectional ◽

End Stage

Backgrounds: Cardio-vascular disorders contribute to mortality in patients suffering end stage kidney disease with peritoneal dialysis. Objectives: (1) To determine the rate of left ventricular systolic dysfunction and left ventricular diastolic disfunction in end-stage chronic renal failure patients treated by CAPD; (2) To evaluate the correlation between left ventricular systolic dysfunction and left ventricular diastolic disfunction Patients-Methods: A cross-sectional design on 30 ESRD patients treated by CAPD at Department of Nephrology- Hue central Hospital were selected for this study from 1/2010 to 6/2011. Results: Stydying left ventricular function in 30 hemodialysis patients in Hue central Hospital by Echo - Doppler, we found 53.33% of cases with left ventricular systolic dysfunction and 56.67% of such patients with left ventricular diastolic dysfunction. Most of these cases (88.23%) had mixed dysfunction. Conclusions: There were relations between left ventricular dysfunction and anemia (Hemoglobinemia), between left ventricular dysfunction and the time of treatement by hemodialysis, but it was not related to hypertension. Key words: left ventricular, Echo – doppler, hemodialysis

Download Full-text

Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies. The OVERCOME trial (preventiOn of left Ventricular dysfunction with Enalapril and caRvedilol in patients submitted to intensive ChemOtherapy for the treatment of Malignant hEmopathies)

Indian Heart Journal ◽

10.1016/j.ihj.2013.08.003 ◽

2013 ◽

Vol 65 (5) ◽

pp. 631-632

Author(s):

Manish Bansal

Keyword(s):

Left Ventricular Dysfunction ◽

Ventricular Dysfunction ◽

Left Ventricular Systolic Dysfunction ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Intensive Chemotherapy ◽

Ventricular Systolic Dysfunction

Download Full-text

Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the If inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction (BEAUTIFUL) Study

American Heart Journal ◽

10.1016/j.ahj.2006.01.013 ◽

2006 ◽

Vol 152 (5) ◽

pp. 860-866 ◽

Cited By ~ 59

Author(s):

Kim Fox ◽

Roberto Ferrari ◽

Michal Tendera ◽

Philippe Gabriel Steg ◽

Ian Ford

Keyword(s):

Ventricular Dysfunction ◽

Left Ventricular Systolic Dysfunction ◽

Controlled Trial ◽

Stable Coronary Artery Disease ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Ventricular Systolic Dysfunction ◽

Double Blind ◽

Double Blind Placebo ◽

Artery Disease

Download Full-text

Evaluation of ventricular systolic dysfunction as a risk factor for acute kidney injury in intensive care unit

The Egyptian Journal of Internal Medicine ◽

10.1186/s43162-021-00055-y ◽

2021 ◽

Vol 33 (1) ◽

Author(s):

Ahmed Aly Obiedallah ◽

Ashraf Anwar E. L. Shazly ◽

Noura Gamal Nasr ◽

Essam M. Abdel Aziz

Keyword(s):

Heart Failure ◽

Acute Kidney Injury ◽

Right Ventricular ◽

Left Ventricular Dysfunction ◽

Ventricular Dysfunction ◽

Systolic Dysfunction ◽

Kidney Injury ◽

Right Ventricular Dysfunction ◽

Left Ventricular ◽

Ventricular Systolic Dysfunction

Abstract Background Heart failure (HF) is a major health problem. Cardiac and renal diseases interact in a complex bidirectional manner in both acute and chronic settings. Renal dysfunction in the setting of heart failure, termed the cardio renal syndrome (CRS), has been considered consequence of left ventricular dysfunction (LVD), whereby decreasing cardiac output (COP) results in renal under perfusion and consequent decreased glomerular filtration rate (GFR). Main body of the abstract This study showed that 500 patients were admitted to internal care unit (ICU), and out of them, 100 (20%) patients developed acute kidney injury (AKI) while 400 (80%) patients did not develop AKI. It is also showed that 67 (67%) of those with AKI and 100 (25%) of those with no-AKI had baseline ventricular systolic dysfunction, left ventricular dysfunction (LVD), right ventricular dysfunction (RVD), and biventricular dysfunction (BiVD)presented in 23 (23%), 16 (16%), and 28 (28%) patients of AKI group, respectively, and presented in 60 (15%), 30 (7.50%), and 10 (2.50%) patients, respectively, in patients without acute kidney injury (AKI) Short conclusion Our study revealed that AKI has highest incidence in patient with biventricular dysfunction followed by left ventricular dysfunction and lastly those with right ventricular dysfunction.

Download Full-text